1. Università degli Studi di Roma Tor Vergata
Indietro

Massimo Andreoni

Qualifica
ORDINARIO
Fonte dei dati: Archivio della Ricerca http://art.torvergata.it
  1. Imeneo, A., Alessio, G., Di Lorenzo, A., Campogiani, L., Lodi, A., Barreca, F., et al. (2022). In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production. LIFE, 12(2) [10.3390/life12020244]. Dettagli
  2. Iannetta, M., Landi, D., Cola, G., Campogiani, L., Malagnino, V., Teti, E., et al. (2022). B- and T-Cell Responses After {SARS}-{CoV}-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications. FRONTIERS IN IMMUNOLOGY, 12, 796482 [10.3389/fimmu.2021.796482]. Dettagli
  3. Mennini, F., Paoletti, M., Bini, C., Marcellusi, A., Falcone, M., & Andreoni, M. (2022). Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP). GLOBAL AND REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 9, 45-57 [10.33393/grhta.2022.2287]. Dettagli
  4. Infante, M., Pieri, M., Lupisella, S., D'Amore, L., Bernardini, S., Fabbri, A., et al. (2021). Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 25(19), 5889-5903 [10.26355/eurrev_202110_26865]. Dettagli
  5. Bouba, Y., Armenia, D., Forbici, F., Bertoli, A., Borghi, V., Gagliardini, R., et al. (2021). Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76(12), 3272-3279 [10.1093/jac/dkab322]. Dettagli
  6. Severa, M., Diotti, R.A., Etna, M.P., Rizzo, F., Fiore, S., Ricci, D., et al. (2021). Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLOS PATHOGENS, 17(9), e1009878 [10.1371/journal.ppat.1009878]. Dettagli
  7. Di Maio, V.C., Barbaliscia, S., Teti, E., Fiorentino, G., Milana, M., Paolucci, S., et al. (2021). Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C. LIVER INTERNATIONAL, 1802-1814 [10.1111/liv.14797]. Dettagli
  8. Iannetta, M., Landi, D., Cola, G., Malagnino, V., Teti, E., Fraboni, D., et al. (2021). T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers. MULTIPLE SCLEROSIS AND RELATED DISORDERS. Dettagli
  9. Tomassetti, F., Nuccetelli, M., Sarubbi, S., Gisone, F., Ciotti, M., Spinazzola, F., et al. (2021). Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection. INTERNATIONAL IMMUNOPHARMACOLOGY, 99, 108013 [10.1016/j.intimp.2021.108013]. Dettagli
  10. Iannetta, M., Buccisano, F., Fraboni, D., Malagnino, V., Campogiani, L., Teti, E., et al. (2021). Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study. SCIENTIFIC REPORTS, 11(1), 12762 [10.1038/s41598-021-90983-0]. Dettagli
  11. Infante, M., Buoso, A., Pieri, M., Lupisella, S., Nuccetelli, M., Bernardini, S., et al. (2021). Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1-16 [10.1080/07315724.2021.1877580]. Dettagli
  12. Alkhatib, M., Di Maio, V.C., De Murtas, V., Polilli, E., Milana, M., Teti, E., et al. (2021). Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b. VIRUSES, 13(5), 743 [10.3390/v13050743]. Dettagli
  13. Andreoni, M., Sticchi, L., Nozza, S., Sarmati, L., Gori, A., Tavio, M., et al. (2021). Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 1-18 [10.1080/21645515.2021.1971473]. Dettagli
  14. Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M.P., Iacovelli, F., et al. (2021). Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences. FRONTIERS IN PHARMACOLOGY, 12, 666600 [10.3389/fphar.2021.666600]. Dettagli
  15. Campione, E., Lanna, C., Cosio, T., Rosa, L., Pia Conte, M., Iacovelli, F., et al. (2021). Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(20), 10985 [10.3390/ijerph182010985]. Dettagli
  16. Cesta, N., Foroghi Biland, L., Neri, B., Mossa, M., Campogiani, L., Caldara, F., et al. (2021). Multiple hepatic and brain abscesses caused by Parvimonas micra: A case report and literature review. ANAEROBE, 69, 102366 [10.1016/j.anaerobe.2021.102366]. Dettagli
  17. Fontana, C., Favaro, M., Laura, C., Vincenzo, M., Silvia, M., Maria Cristina Bossa, ., et al. (2021). Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance. MICROORGANISMS, 9(11), 2356 [10.3390/microorganisms9112356]. Dettagli
  18. Kondili, L., Aghemo, A., Andreoni, M., Galli, M., Rossi, A., Babudieri, S., et al. (2021). Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation. DIGESTIVE AND LIVER DISEASE [10.1016/j.dld.2021.03.026]. Dettagli
  19. Liguori, C., Pierantozzi, M., Spanetta, M., Sarmati, L., Cesta, N., Iannetta, M., et al. (2021). Depressive and anxiety symptoms in patients with SARS-CoV2 infection. BRAIN, BEHAVIOR, & IMMUNITY. HEALTH, 278, 339-340 [10.1016/j.jad.2020.09.042]. Dettagli
  20. Malagnino, V., Cerva, C., Cingolani, A., Ceccherini-Silberstein, F., Vergori, A., Cuomo, G., et al. (2021). HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients. OPEN FORUM INFECTIOUS DISEASES, 8(1), 1-8 [10.1093/ofid/ofaa566]. Dettagli
  21. Malagnino, V., Cerva, C., Teti, E., Campogiani, L., Compagno, M., Foroghi Biland, L., et al. (2021). Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers. SCIENTIFIC REPORTS, 11(1), 3965 [10.1038/s41598-021-83616-z]. Dettagli
  22. Malagnino, V., Teti, E., Compagno, M., Coppola, L., Salpini, R., Svicher, V., et al. (2021). HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort. MICROORGANISMS, 9(2), 1-13 [10.3390/microorganisms9020396]. Dettagli
  23. Matteucci, C., Minutolo, A., Balestrieri, E., Petrone, V., Fanelli, M., Malagnino, V., et al. (2021). Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients. OPEN FORUM INFECTIOUS DISEASES, 8(1), ofaa588 [10.1093/ofid/ofaa588]. Dettagli
  24. Mennini, F., Gori, M., Vlachaki, I., Fiorentino, F., La Malfa, P., Urbinati, D., et al. (2021). Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy. HEALTH ECONOMICS REVIEW [10.1186/s13561-021-00341-z]. Dettagli
  25. Minosse, S., Picchi, E., Di Giuliano, F., Sarmati, L., Teti, E., Pistolese, C., et al. (2021). Functional brain network reorganization in HIV infection. JOURNAL OF NEUROIMAGING, 31(4), 796-808 [10.1111/jon.12861]. Dettagli
  26. Minutolo, A., Petrone, V., Fanelli, M., Iannetta, M., Giudice, M., Ait Belkacem, I., et al. (2021). High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients. PATHOGENS [10.20944/preprints202105.0731.v1]. Dettagli
  27. Minutolo, A., Petrone, V., Fanelli, M., Iannetta, M., Giudice, M., Ait Belkacem, I., et al. (2021). High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients. PATHOGENS, 10(12) [10.3390/pathogens10121639]. Dettagli
  28. Piermatteo, L., Mohammad, A., Stefano, D., Vincenzo, M., Bertoli, A., Eleonora, A., et al. (2021). HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation. BIOMEDICINES, 9(10), 1352 [10.3390/biomedicines9101352]. Dettagli
  29. Piermatteo, L., Scutari, R., Chirichiello, R., Alkhatib, M., Malagnino, V., Bertoli, A., et al. (2021). Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment. METHODS [10.1016/j.ymeth.2021.05.011]. Dettagli
  30. Scucchi, L., Neri, B., Sarmati, L., Mossa, M., Sena, G., Massoud, R., et al. (2021). Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 25(5), 2418-2424 [10.26355/eurrev_202103_25283]. Dettagli
  31. Macchi, B., Frezza, C., Marino-Merlo, F., Minutolo, A., Stefanizzi, V., Balestrieri, E., et al. (2020). Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients. PATHOGENS, 9(12), 1-9 [10.3390/pathogens9121047]. Dettagli
  32. Salpini, R., Battisti, A., Piermatteo, L., Carioti, L., Anastasiou, O.E., Gill, U.S., et al. (2020). Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. EMERGING MICROBES & INFECTIONS, 9(1), 928-939 [10.1080/22221751.2020.1757998]. Dettagli
  33. Scutari, R., Piermatteo, L., Ciancio Manuelli, M., Iannetta, M., Salpini, R., Bertoli, A., et al. (2020). Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis. LIFE, 10(11), 1-9 [10.3390/life10110302]. Dettagli
  34. Scutari, R., Piermatteo, L., Ciancio Manuelli, M., Iannetta, M., Salpini, R., Bertoli, A., et al. (2020). Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis. LIFE, 10(11) [10.3390/life10110302]. Dettagli
  35. Novelli, A., Andreani, M., Biancolella, M., Liberatoscioli, L., Passarelli, C., Colona, V.L., et al. (2020). HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA, 96(5), 610-614 [10.1111/tan.14047]. Dettagli
  36. Amati, F., Vancheri, C., Latini, A., Colona, V.L., Grelli, S., D'Apice, M.R., et al. (2020). Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients. HELIYON, 6(10), e05143 [10.1016/j.heliyon.2020.e05143]. Dettagli
  37. Iannetta, M., Cesta, N., Stingone, C., Malagnino, V., Teti, E., Vitale, P., et al. (2020). Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 45, 102442 [10.1016/j.msard.2020.102442]. Dettagli
  38. Armenia, D., Bouba, Y., Gagliardini, R., Gori, C., Bertoli, A., Borghi, V., et al. (2020). Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings. JOURNAL OF CLINICAL VIROLOGY, 130, 104534 [10.1016/j.jcv.2020.104534]. Dettagli
  39. Latini, A., Agolini, E., Novelli, A., Borgiani, P., Giannini, R., Gravina, P., et al. (2020). COVID-19 and genetic variants of protein involved in the SARS-CoV-2 entry into the host cells. GENES, 11(9). Dettagli
  40. Rizza, S., Coppeta, L., Grelli, S., Ferrazza, G., Chiocchi, M., Vanni, G., et al. (2020). High body mass index and night shift work are associated with COVID-19 in health care workers. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Dettagli
  41. Adorni, F., Prinelli, F., Bianchi, F., Giacomelli, A., Pagani, G., Bernacchia, D., et al. (2020). Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population in Italy: cross-sectional study of the EPICOVID19 web-based survey. JMIR PUBLIC HEALTH AND SURVEILLANCE, 6(3), 461-474 [10.2196/21866]. Dettagli
  42. Salpini, R., Piermatteo, L., Battisti, A., Colagrossi, L., Aragri, M., Yu La Rosa, K., et al. (2020). A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro. VIRUSES, 12(2), 251 [10.3390/v12020251]. Dettagli
  43. Arcese, W., Cerretti, R., Sarmati, L., Cudillo, L., De Angelis, G., Mariotti, B., et al. (2020). MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION [10.1016/j.bbmt.2020.02.005]. Dettagli
  44. Fontana, C., Angeletti, S., Mirandola, W., Cella, E., Alessia, L., Zehender, G., et al. (2020). Whole genome sequencing of carbapenem-resistant Klebsiella pneumoniae: evolutionary analysis for outbreak investigation. FUTURE MICROBIOLOGY, 15(3), 203-212 [10.2217/fmb-2019-0074]. Dettagli
  45. Armenia, D., Di Carlo, D., Flandre, P., Bouba, Y., Borghi, V., Forbici, F., et al. (2020). HIV MDR is still a relevant issue despite its dramatic drop over the years. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75(5), 1301-1310 [10.1093/jac/dkz554]. Dettagli
  46. Soulie, C., Santoro, M.M., Storto, A., Abdi, B., Charpentier, C., Armenia, D., et al. (2020). Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkz553]. Dettagli
  47. Formica, V., Minieri, M., Bernardini, S., Ciotti, M., D'Agostini, C., Roselli, M., et al. (2020). Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2. CLINICAL MEDICINE, 20(4), 114-119 [10.7861/clinmed.2020-0373]. Dettagli
  48. Iannetta, M., Cesta, N., Stingone, C., Malagnino, V., Teti, E., Vitale, P., et al. (2020). Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 45, 102442 [10.1016/j.msard.2020.102442]. Dettagli
  49. Kondili, L., Mennini, F., Andreoni, M., Babudieri, S., Gardini, I., Rossi, A., et al. (2020). Verso una politica sanitaria di screening e linkage to care per l’eliminazione dell’infezione da epatite C in Italia. LE INFEZIONI IN MEDICINA, Speciale 2, 5-28. Dettagli
  50. Marcellusi, A., Bini, C., Andreoni, M., Sarmati, L., Espin, J., P Horcajada, J., et al. (2020). Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries. CLINICAL DRUG INVESTIGATION, 40(4), 305-318. Dettagli
  51. Minosse, S., Picchi, E., Di Giuliano, F., Lanzafame, S., Manenti, G., Pistolese, C., et al. (2020). Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infection. In Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS (pp.1726-1729). IEEE. Dettagli
  52. Minosse, S., Picchi, E., Giuliano, F.D., Lanzafame, S., Manenti, G., Pistolese, C.A., et al. (2020). Disruption of brain network organization in patients with human immunodeficiency virus (HIV) infection. Paper presented at EMBC 2020 [10.1109/EMBC44109.2020.9176449]. Dettagli
  53. Novelli, A., Biancolella, M., Borgiani, P., Cocciadiferro, D., Colona, V.L., D'Apice, M.R., et al. (2020). Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. HUMAN GENOMICS, 14(1), 29 [10.1186/s40246-020-00279-z]. Dettagli
  54. Novelli, A., Biancolella, M., Borgiani, P., Cocciadiferro, D., Colona, V.L., D’Apice, M.R., et al. (2020). No evidence for allelic association between Covid-19 and ACE2 genetic variants by direct exome sequencing in 99 SARS-CoV-2 positive patients [Sito web] [10.1101/2020.05.23.20111310]. Dettagli
  55. Nuccetelli, M., Pieri, M., Grelli, S., Ciotti, M., Miano, R., Andreoni, M., et al. (2020). SARS-CoV-2 infection serology: a useful tool to overcome lockdown?. CELL DEATH DISCOVERY, 6(1), 38. Dettagli
  56. Prezioso, C., Bianchi, M., Obregon, F., Ciotti, M., Sarmati, L., Andreoni, M., et al. (2020). Structural Analysis of Merkel Cell Polyomavirus (MCPyV) Viral Capsid Protein 1 (VP1) in HIV-1 Infected Individuals. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(21), 1-20 [10.3390/ijms21217998]. Dettagli
  57. Prezioso, C., Obregon, F., Ambroselli, D., Petrolo, S., Checconi, P., Maria Rodio, D., et al. (2020). Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability among a HIV-1-Positive Population. VIRUSES, 12(5), 507 [10.3390/v12050507]. Dettagli
  58. Salpini, R., Malagnino, V., Piermatteo, L., Mulas, T., Alkhatib, M., Scutari, R., et al. (2020). Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers. MICROORGANISMS, 8(11), 1-12 [10.3390/microorganisms8111819]. Dettagli
  59. Bordoni, V., Brando, B., Piselli, P., Forini, O., Perna, F.e., Atripaldi, U., et al. (2019). Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study. PLOS ONE, 14(12), e0225415 [10.1371/journal.pone.0225415]. Dettagli
  60. Campogiani, L., Compagno, M., Coppola, L., Malagnino, V., Maffongelli, G., Saraca, L.m., et al. (2019). Tuberculosis-related hospitalizations in a low-incidence country: A retrospective analysis in two Italian infectious diseases wards. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 17(1), 124 [10.3390/ijerph17010124]. Dettagli
  61. Grossi, P.a., Baldanti, F., Andreoni, M., & Perno, C.f. (2019). CMV infection management in transplant patients in Italy. JOURNAL OF CLINICAL VIROLOGY, 104211 [10.1016/j.jcv.2019.104211]. Dettagli
  62. Foroghi Biland, L., Ferrari, L., Malagnino, V., Teti, E., Cerva, C., Gentile, A., et al. (2019). Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: A case report. JOURNAL OF MEDICAL CASE REPORTS, 13(1), 299 [10.1186/s13256-019-2232-3]. Dettagli
  63. Molinaro, S., Resce, G., Alberti, A., Andreoni, M., D'Egidio, P., Leonardi, C., et al. (2019). Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinics. DRUG AND ALCOHOL REVIEW, 38(6), 644-655-655 [10.1111/dar.12978]. Dettagli
  64. Malagnino, V., Cerva, C., Maffongelli, G., Teti, E., Foroghi Biland, L., Cesta, N., et al. (2019). HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy. SCIENTIFIC REPORTS, 9(1), 11942 [10.1038/s41598-019-46976-1]. Dettagli
  65. Salpini, R., Battisti, A., Colagrossi, L., Di Carlo, D., Fabeni, L., Piermatteo, L., et al. (2019). A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection. JOURNAL OF VIRAL HEPATITIS, 26(7), 846-855 [10.1111/jvh.13101]. Dettagli
  66. Scutari, R., Alteri, C., Vicenti, I., Carlo, D.D., Zuccaro, V., Incardona, F., et al. (2019). Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE [10.1016/j.jgar.2019.07.015]. Dettagli
  67. Garaci, F., Picchi, E., Di Giuliano, F., Lanzafame, S., Minosse, S., Manenti, G., et al. (2019). Cerebral Multishell Diffusion Imaging Parameters are Associated with Blood Biomarkers of Disease Severity in HIV Infection. JOURNAL OF NEUROIMAGING [10.1111/jon.12655]. Dettagli
  68. Alteri, C., Scutari, R., Stingone, C., Maffongelli, G., Brugneti, M., Falasca, F., et al. (2019). Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success. JOURNAL OF CLINICAL VIROLOGY, 117, 61-67 [10.1016/j.jcv.2019.06.004]. Dettagli
  69. Campogiani, L., Cerva, C., Maffongelli, G., Teti, E., Pupo, L., Vaccarini, S., et al. (2019). Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir. AIDS RESEARCH AND THERAPY, 16(1), 15 [10.1186/s12981-019-0230-6]. Dettagli
  70. Parisi, S.g., Basso, M., Scaggiante, R., Andreis, S., Mengoli, C., Cruciani, M., et al. (2019). Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications. BMC PUBLIC HEALTH, 19(1), 645 [10.1186/s12889-019-7004-x]. Dettagli
  71. Fabeni, L., Alteri, C., Berno, G., Scutari, R., Orchi, N., De Carli, G., et al. (2019). Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy. SEXUALLY TRANSMITTED INFECTIONS, 95(8), 619-625 [10.1136/sextrans-2019-054017]. Dettagli
  72. Armenia, D., Di Carlo, D., Cozzi-Lepri, A., Calcagno, A., Borghi, V., Gori, C., et al. (2019). Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. ANTIVIRAL THERAPY, 24(5), 321-331. Dettagli
  73. Mengoli, C., Basso, M., Andreis, S., Scaggiante, R., Cruciani, M., Ferretto, R., et al. (2019). Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach. PLOS ONE, 14(3), e0213160 [10.1371/journal.pone.0213160]. Dettagli
  74. Antinori, A., Santoro, M.m., Gagliardini, R., Marchetti, G., Mondi, A., Cento, V., et al. (2019). Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients. NEW MICROBIOLOGICA, 42(2), 69-80. Dettagli
  75. Sterrantino, G., Borghi, V., Callegaro, A.p., Bruzzone, B., Saladini, F., Maggiolo, F., et al. (2019). Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS [10.1016/j.ijantimicag.2019.02.007]. Dettagli
  76. Malagnino, V., Cerva, C., Teti, E., Maffongelli, G., Andreoni, M., & Sarmati, L. (2019). Abnormal elevation of international normalized ratio in a patient during the coadministration of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and warfarin: a case report. AIDS, 33(2), 360-361-361 [10.1097/QAD.0000000000002097]. Dettagli
  77. Alteri, C., Scutari, R., Bertoli, A., Armenia, D., Gori, C., Fabbri, G., et al. (2019). Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice. VIRUS GENES [10.1007/s11262-019-01649-z]. Dettagli
  78. Cella, E., Leoni, D., Mirandola, W., Fontana, C., Sarmati, L., Andreoni, M., et al. (2019). A67 Bloodstream infections by carbapenem-resistant Klebsiella pneumoniae subsp. pneumoniae: Bayesian phylogenetic analysis of whole genomes. VIRUS EVOLUTION [10.1093/ve/vez002.066]. Dettagli
  79. Delle Rose, D., Pezzotti, P., Fontana, C., Altieri, A., Minelli, S., Mariotti, B., et al. (2019). An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital. INFECTIOUS DISEASES, 51(1), 12-22 [10.1080/23744235.2018.1492149]. Dettagli
  80. Falcone, M., Tiseo, G., Gutierrez-Gutierrez, B., Raponi, G., Carfagna, P., Rosin, C., et al. (2019). Impact of initial antifungal therapy on the outcome of patients with candidemia and septic shock admitted to medical wards: A propensity score-adjusted analysis. OPEN FORUM INFECTIOUS DISEASES, 6(7), ofz251 [10.1093/ofid/ofz251]. Dettagli
  81. Falcone, M., Tiseo, G., Iraci, F., Raponi, G., Goldoni, P., Delle Rose, D., et al. (2019). Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. CLINICAL MICROBIOLOGY AND INFECTION, 25(4), 474-480 [10.1016/j.cmi.2018.06.020]. Dettagli
  82. Marcellusi, A., Viti, R., Sarmati, L., Streinu-Cercel, A., Pana, A., Espin, J., et al. (2019). Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of 3 European Countries. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. Dettagli
  83. Salpini, R., Surdo, M., Cortese, M., Palumbo, G., Carioti, L., Cappiello, G., et al. (2019). The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. CLINICAL MICROBIOLOGY AND INFECTION, 25(7) [10.1016/j.cmi.2018.11.017]. Dettagli
  84. Trunfio, M., Pinnetti, C., Focà, E., Bai, F., Maffongelli, G., Celani, L., et al. (2019). Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?. AIDS, 33(4), 759-762 [10.1097/QAD.0000000000002091]. Dettagli
  85. Viganò, M., Andreoni, M., Perno, C.f., Craxì, A., Aghemo, A., Alberti, A., et al. (2019). Real life experiences in HCV management in 2018. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 17(2), 117-128 [10.1080/14787210.2019.1563755]. Dettagli
  86. Babiloni, C., Noce, G., Pennica, A., Onorati, P., Capotosto, P., Del Percio, C., et al. (2018). Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals. CLINICAL NEUROPHYSIOLOGY, 129(2), 431-441 [10.1016/j.clinph.2017.12.002]. Dettagli
  87. Basso, M., Andreis, S., Scaggiante, R., Franchin, E., Zago, D., Biasolo, M.a., et al. (2018). Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study. BMC INFECTIOUS DISEASES, 18(1), 683 [10.1186/s12879-018-3591-x]. Dettagli
  88. Alteri, C., Fabeni, L., Scutari, R., Berno, G., Di Carlo, D., Gori, C., et al. (2018). Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence. SCIENTIFIC REPORTS, 8(1), 15739. Dettagli
  89. Antinori, A., Di Biagio, A., Marcotullio, S., Sarmati, L., Andreoni, M., Angarano, G., et al. (2018). Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. NEW MICROBIOLOGICA, 41(4), 247-255. Dettagli
  90. Ceccherini-Silberstein, F., Cozzi Lepri, A., Alteri, C., Merlini, E., Surdo, M., Marchetti, G., et al. (2018). Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73(12), 3460-3470 [10.1093/jac/dky350]. Dettagli
  91. Masetti, C., Lionetti, R., Lupo, M., Siciliano, M., Giannelli, V., Ponziani, F.r., et al. (2018). Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. JOURNAL OF VIRAL HEPATITIS [10.1111/jvh.12982]. Dettagli
  92. Parisi, S.g., Andreis, S., Mengoli, C., Menegotto, N., Cavinato, S., Scaggiante, R., et al. (2018). Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 207(3-4), 183-194 [10.1007/s00430-018-0538-1]. Dettagli
  93. Colagrossi, L., Salpini, R., Scutari, R., Carioti, L., Battisti, A., Piermatteo, L., et al. (2018). HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets. VIRUSES, 10(7), 363 [10.3390/v10070363]. Dettagli
  94. Bertoli, A., Sorbo, M.C., Aragri, M., Lenci, I., Teti, E., Polilli, E., et al. (2018). Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. SCIENTIFIC REPORTS, 8(1), 8988 [10.1038/s41598-018-26862-y]. Dettagli
  95. Borderi, M., Angarano, G., Antinori, A., Chirianni, A., Cinque, P., D'Arminio Monforte, A., et al. (2018). Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessment. NEW MICROBIOLOGICA, 41(2), 112-117. Dettagli
  96. Andreoni, M., Babudieri, S., Bruno, S., Colombo, M., Zignego, A.l., Di Marco, V., et al. (2018). Current and future challenges in HCV: insights from an Italian experts panel. INFECTION, 46(2), 147-163 [10.1007/s15010-017-1093-1]. Dettagli
  97. Ceccherini-Silberstein, F., Cozzi Lepri, A., Alteri, C., Merlini, E., Surdo, M., Marchetti, G., et al. (2018). Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73(12), 3460-3470 [10.1093/jac/dky350]. Dettagli
  98. Malagnino, V., Salpini, R., Maffongelli, G., Battisti, A., Fabeni, L., Piermatteo, L., et al. (2018). High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance. PLOS ONE, 13(3), e0195045 [10.1371/journal.pone.0195045]. Dettagli
  99. Santoro, M., Di Carlo, D., Armenia, D., Zaccarelli, M., Pinnetti, C., Colafigli, M., et al. (2018). Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. ANTIVIRAL THERAPY, 23(3), 249-257 [10.3851/IMP3197]. Dettagli
  100. Taramasso, L., Biagio, A.d., Bovis, F., Nicolini, L.a., Antinori, A., Milazzo, L., et al. (2018). Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients. PLOS ONE, 13(2), e0192627 [10.1371/journal.pone.0192627]. Dettagli
  101. Andreoni, M., Mussi, C., Bellagamba, R., Di Campli, F., Montinaro, V., & Babiloni, C. (2017). Biomarkers of monitoring and functional reserve of physiological systems over time in HIV: expert opinions for effective secondary prevention. NEW MICROBIOLOGICA, 40(4). Dettagli
  102. Giuliani, E., Vassena, L., Nulls, N., Malagnino, V., Desimio M., G., Andreoni, M., et al. (2017). NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells. IMMUNOLOGY LETTERS, 190, 185-193 [10.1016/j.imlet.2017.08.014]. Dettagli
  103. Cento, V., Aragri, M., Teti, E., Polilli, E., Bertoli, A., Foroghi, L., et al. (2017). Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkx302]. Dettagli
  104. Parisi, S., Andreis, S., Basso, M., Cavinato, S., Scaggiante, R., Franzetti, M., et al. (2017). Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 206(6), 419-428 [10.1007/s00430-017-0518-x]. Dettagli
  105. Andreis, S., Basso, M., Scaggiante, R., Cruciani, M., Ferretto, R., Manfrin, V., et al. (2017). Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 10, 106-112 [10.1016/j.jgar.2017.05.011]. Dettagli
  106. Fabeni, L., Berno, G., Fokam, J., Bertoli, A., Alteri, C., Gori, C., et al. (2017). Comparative evaluation of subtyping tools for the surveillance of newly emerging HIV-1 strains. JOURNAL OF CLINICAL MICROBIOLOGY, JCM.00656-17 [10.1128/JCM.00656-17]. Dettagli
  107. Monforte, A.d., Cozzi-Lepri, A., Ceccherini-Silberstein, F., De Luca, A., Caputo, S.l., Castagna, A., et al. (2017). Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort. PLOS ONE, 12(5), e0177402 [10.1371/journal.pone.0177402]. Dettagli
  108. Moscato, G., Giacobbi, E., Anemona, L., Di Cesare, S., Di Matteo, G., Andreoni, M., et al. (2017). Dysplasia of Granulocytes in a Patient with HPV Disease, Recurrent Infections, and B Lymphopenia: A Novel Variant of WHIM Syndrome?. FRONTIERS IN PEDIATRICS, 5, 95 [10.3389/fped.2017.00095]. Dettagli
  109. Antinori, A., Di Biagio, A., Marcotullio, S., Andreoni, M., Chirianni, A., D'arminio Monforte, A., et al. (2017). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016. NEW MICROBIOLOGICA, 40(2), 86-98. Dettagli
  110. Gianotti, N., Cozzi-Lepri, A., Antinori, A., Castagna, A., De Luca, A., Celesia, B.m., et al. (2017). Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients. PLOS ONE, 12(2), e0171611 [10.1371/journal.pone.0171611]. Dettagli
  111. Di Maio, V., Cento, V., Lenci, I., Aragri, M., Rossi, P., Barbaliscia, S., et al. (2017). Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies. LIVER INTERNATIONAL, 37(4), 514-528 [10.1111/liv.13327]. Dettagli
  112. Jaffré, J., Armenia, D., Bellocchi, M.c., Wirden, M., Carioti, L., Lambert, S., et al. (2017). Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72(5), 1537-1539 [10.1093/jac/dkw571]. Dettagli
  113. Armenia, D., Di Carlo, D., Maffongelli, G., Borghi, V., Alteri, C., Forbici, F., et al. (2017). Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens. HIV MEDICINE [10.1111/hiv.12388]. Dettagli
  114. Babiloni, C., Pennica, A., Del Percio, C., Noce, G., Cordone, S., Muratori, C., et al. (2017). Corrigendum to “Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index” [Clin. Neurophysiol. 127 (2016) 1803–1812] (S138824571501559X) (10.1016/j.clinph.2015.12.007)). CLINICAL NEUROPHYSIOLOGY, 128(1), 287-287 [10.1016/j.clinph.2016.11.002]. Dettagli
  115. Babiloni, C., Pennica, A., Capotosto, P., Onorati, P., Muratori, C., Ferracuti, S., et al. (2017). Corrigendum to “Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study” [Clin. Neurophysiol. 127 (2016) 3455–3469]((S1388245716305089)(10.1016/j.clinph.2016.09.001)). CLINICAL NEUROPHYSIOLOGY, 128(1), 288 [10.1016/j.clinph.2016.11.003]. Dettagli
  116. Cento, V., Nguyen, T., Di Carlo, D., Biliotti, E., Gianserra, L., Lenci, I., et al. (2017). Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens. PLOS ONE, 12(5), e0177352 [10.1371/journal.pone.0177352]. Dettagli
  117. Fabeni, L., Alteri, C., Di Carlo, D., Orchi, N., Carioti, L., Bertoli, A., et al. (2017). Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72(10), 2837-2845 [10.1093/jac/dkx231]. Dettagli
  118. Gentile, G., Andreoni, M., Antonelli, G., & Sarmati, L. (2017). Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review. CLINICAL MICROBIOLOGY AND INFECTION, 23(12), 916-923 [10.1016/j.cmi.2017.06.024]. Dettagli
  119. Mengoli, C., Andreis, S., Scaggiante, R., Cruciani, M., Bosco, O., Ferretto, R., et al. (2017). Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 72(1), 220-226 [10.1093/jac/dkw348]. Dettagli
  120. Parisi, S.G., Basso, M., Mengoli, C., Scaggiante, R., Andreis, S., Franzetti M., M., et al. (2017). Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection. ANNALS OF GASTROENTEROLOGY, 30(5), 534-541 [10.20524/aog.2017.0175]. Dettagli
  121. Petta, S., Marzioni, M., Russo, P., Aghemo, A., Alberti, A., Ascione, A., et al. (2017). Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study. THE LANCET. GASTROENTEROLOGY & HEPATOLOGY, 2(6), 427-434 [10.1016/S2468-1253(17)30048-1]. Dettagli
  122. Ricciardi, A., Gentilotti, E., Coppola, L., Maffongelli, G., Cerva, C., Malagnino, V., et al. (2017). Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients. PLOS ONE, 12(5), e0176881 [10.1371/journal.pone.0176881]. Dettagli
  123. Russo, M., Nardi, P., Saitto, G., Sordillo, P., Colella, D.f., Andreoni, M., et al. (2017). Paravalvular leak of a mechanical mitral valve prosthesis associated with Burkholderia cepacia subacute endocarditis: A rare case successfully treated by multidisciplinary approach. KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 14(3), 200-202 [10.5114/kitp.2017.70535]. Dettagli
  124. Sarmati, L., Andreoni, M., Antonelli, G., Arcese, W., Bruno, R., Coppola, N., et al. (2017). Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper. CLINICAL MICROBIOLOGY AND INFECTION, 23(12), 935-940 [10.1016/j.cmi.2017.06.023]. Dettagli
  125. Armenia, D., Di Carlo, D., Calcagno, A., Vendemiati, G., Forbici, F., Bertoli, A., et al. (2016). Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, dkw512 [10.1093/jac/dkw512]. Dettagli
  126. Alteri, C., Surdo, M., Di Maio, V., Di Santo, F., Costa, G., Parrotta, L., et al. (2016). The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 7, 1-7 [10.1016/j.jgar.2016.06.005]. Dettagli
  127. Vassena, L., Giuliani, E., Buonomini, A.r., Malagnino, V., Andreoni, M., & Doria, M. (2016). Brief report: L-selectin (CD62L) is downregulated on CD4+ and CD8+ T lymphocytes of HIV-1-infected individuals naive for ART. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 72(5), 492-497 [10.1097/QAI.0000000000000999]. Dettagli
  128. Cerva, C., Colagrossi, L., Maffongelli, G., Salpini, R., Di Carlo, D., Malagnino, V., et al. (2016). Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor. CLINICAL MICROBIOLOGY AND INFECTION, 22(11), 946.e1-946.e8 [10.1016/j.cmi.2016.07.021]. Dettagli
  129. Moscato, G., Di Matteo, G., Ciotti, M., Di Bonito, P., Andreoni, M., & Moschese, V. (2016). Dual response to human papilloma virus vaccine in an immunodeficiency disorder: Resolution of plantar warts and persistence of condylomas. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 30(7), 1212-1213 [10.1111/jdv.13133]. Dettagli
  130. Winston, A., Stohr, W., Antinori, A., Arenas-Pinto, A., Llibre, J.m., Amieva, H., et al. (2016). Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy. HIV MEDICINE, 17(6), 471-478 [10.1111/hiv.12344]. Dettagli
  131. Gregson, J., Tang, M., Ndembi, N., Hamers, R.L., Marconi, V.C., Brooks, K., et al. (2016). Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study. THE LANCET INFECTIOUS DISEASES, 16(5), 565-575 [10.1016/S1473-3099(15)00536-8]. Dettagli
  132. Antinori, A., Marcotullio, S., Andreoni, M., Chirianni, A., D'arminio Monforte, A., Di Biagio, A., et al. (2016). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015. NEW MICROBIOLOGICA, 39(2), 93-109. Dettagli
  133. Andreoni, M., d'Angela, D., Mancusi, R.L., Sarrecchia, C., & Spandonaro, F. (2016). Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype. MEDICINE, 95(42) [10.1097/MD.0000000000005143]. Dettagli
  134. Babiloni, C., Pennica, A., Capotosto, P., Onorati, P., Muratori, C., Ferracuti, S., et al. (2016). Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study. CLINICAL NEUROPHYSIOLOGY, 127(11), 3455-3469 [10.1016/j.clinph.2016.09.001]. Dettagli
  135. Babiloni, C., Pennica, A., Del Percio, C., Noce, G., Cordone, S., Muratori, C., et al. (2016). Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index. CLINICAL NEUROPHYSIOLOGY, 127(3), 1803-1812 [10.1016/j.clinph.2015.12.007]. Dettagli
  136. Babiloni, C., Pennica, A., Nullc, N.p., Noce, G., Cordone, S., Lopez, S., et al. (2016). Antiretroviral therapy affects the z-score index of deviant cortical EEG rhythms in naïve HIV individuals. NEUROIMAGE. CLINICAL, 12, 144-156 [10.1016/j.nicl.2016.06.005]. Dettagli
  137. Delle Rose, D., Pezzotti, P., Fortunato, E., Sordillo, P., Gini, S., Boros, S., et al. (2016). Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 35(9), 1531-1539 [10.1007/s10096-016-2694-9]. Dettagli
  138. Di Maio, V., Cento, V., Di Paolo, D., Aragri, M., De Leonardis, F., Tontodonati, M., et al. (2016). HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71(3), 739-750 [10.1093/jac/dkv403]. Dettagli
  139. Maffongelli, G., Alterib, C., Gentilotti, E., Bertoli, A., Ricciardi, A., Malagnino, V., et al. (2016). Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy. AIDS [10.1097/QAD.0000000000000977]. Dettagli
  140. Marcellusi, A., Viti, R., Russo, S., Andreoni, M., Antinori, A., & Mennini, F.S. (2016). Early treatment in HIV patients: a cost–utility analysis from the Italian perspective. CLINICAL DRUG INVESTIGATION, 36(5), 377-387 [10.1007/s40261-016-0382-2]. Dettagli
  141. Salpini, R., Fokam, J., Ceccarelli, L., Santoro, M., Nanfack, A., Sosso, S., et al. (2016). High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians. CURRENT HIV RESEARCH, 14(2), 165-171 [10.2174/1570162X13666150930114742]. Dettagli
  142. Zaccarelli, M., Santoro, M.m., Armenia, D., Borghi, V., Gennari, W., Gori, C., et al. (2016). Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA. JOURNAL OF CLINICAL VIROLOGY, 82, 94-100 [10.1016/j.jcv.2016.07.007]. Dettagli
  143. Giuliani, E., Vassena, L., Desimio, M.g., Buonomini, A.r., Malagnino, V., Andreoni, M., et al. (2015). Expression and Function of NKG2D Is Impaired in CD8+ T Cells of Chronically HIV-1-Infected Patients Without ART. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 70(4), 347-356 [10.1097/QAI.0000000000000792]. Dettagli
  144. Andreoni, M., Marcotullio, S., Puro, V., De Carli, G., Tambussi, G., Nozza, S., et al. (2015). An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project. NEW MICROBIOLOGICA, 38(4), 443-490. Dettagli
  145. Salpini, R., Colagrossi, L., Bellocchi, M., Surdo, M., Becker, C., Alteri, C., et al. (2015). Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. HEPATOLOGY, 61(3), 823-833 [10.1002/hep.27604]. Dettagli
  146. Surdo, M., Bertoli, A., Colucci, G., Sarmati, L., Andreoni, M., Perno, C.F., et al. (2015). Total HIV-1 DNA detection and quantification in peripheral blood by COBAS®AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 54(2), e57-e59 [10.1515/cclm-2015-0647]. Dettagli
  147. Antinori, A., Marcotullio, S., Andreoni, M., Ammassari, A., d'Arminio Monforte, A., Galli, M., et al. (2015). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014. NEW MICROBIOLOGICA, 38(3), 299-328. Dettagli
  148. Fabeni, L., Berno, G., Svicher, V., Ceccherini-Silberstein, F., Gori, C., Bertoli, A., et al. (2015). Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia. JOURNAL OF CLINICAL MICROBIOLOGY, 53(9), 2935-2941 [10.1128/JCM.00893-15]. Dettagli
  149. Antinori, A., Andreoni, M., Perno, C.f., & Lazzarin, A. (2015). HEFFICON: HIV Effectiveness Italian Conference. NEW MICROBIOLOGICA, 38(2), 149-184. Dettagli
  150. Cento, V., Di Paolo, D., Di Carlo, D., Micheli, V., Tontodonati, M., De Leonardis, F., et al. (2015). Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome. DIGESTIVE AND LIVER DISEASE, 47(2), 157-163 [10.1016/j.dld.2014.11.010]. Dettagli
  151. Armenia, D., Fabeni, L., Alteri, C., Di Pinto, D., Di Carlo, D., Bertoli, A., et al. (2015). HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 70(6), 1865-1873 [10.1093/jac/dkv029]. Dettagli
  152. Camoni, L., Raimondo, M., Dorrucci, M., Regine, V., Salfa, M.c., Suligoi, B., et al. (2015). Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 31(3), 282-287 [10.1089/aid.2014.0154]. Dettagli
  153. Delle Rose, D., Sordillo, P., Gini, S., Cerva, C., Boros, S., Rezza, G., et al. (2015). Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals. AMERICAN JOURNAL OF INFECTION CONTROL [10.1016/j.ajic.2015.06.023]. Dettagli
  154. Fabeni, L., Alteri, C., Orchi, N., Gori, C., Bertoli, A., Forbici, F., et al. (2015). Recent transmission clustering of HIV-1 C and CRF17-BF strains characterized by NNRTI-related mutations among newly diagnosed men in central Italy. PLOS ONE, 10(8), e0135325 [10.1371/journal.pone.0135325]. Dettagli
  155. Parisi, S.G., Sarmati, L., Andreis, S., Scaggiante, R., Cruciani, M., Ferretto, R., et al. (2015). Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy. CLINICAL MICROBIOLOGY AND INFECTION, 21(3), 288.e5-288.e7 [10.1016/j.cmi.2014.10.009]. Dettagli
  156. Sarmati, L., D'Ettorre, G., Parisi, S.g., & Andreoni, M. (2015). HIV replication at low copy number and its correlation with the HIV reservoir: A clinical perspective. CURRENT HIV RESEARCH, 13(3), 250-257 [10.2174/1570162X13666150407142539]. Dettagli
  157. Andreoni, M. (2014). [Simplification of antiretroviral therapy: proposal for a score for the evaluation of patients with suppressed viremia]. RECENTI PROGRESSI IN MEDICINA, 105(12), 462-8 [10.1701/1706.18618]. Dettagli
  158. Mirabelli, C., Surdo, M., Van Hemert, F., Lian, Z., Salpini, R., Cento, V., et al. (2014). Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection. JOURNAL OF INFECTION [10.1016/j.jinf.2014.10.015]. Dettagli
  159. Mengoli, C., Andreis, S., Scaggiante, R., Cruciani, M., Bosco, O., Ferretto, R., et al. (2014). Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY [10.7448/IAS.17.4.19679]. Dettagli
  160. Ricciardi, A., Sordillo, P., Ceccarelli, L., Maffongelli, G., Calisti, G., Di Pietro, B., et al. (2014). 18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 28, 219-224 [10.1016/j.ijid.2014.04.028]. Dettagli
  161. Armignacco, O., Andreoni, M., Sagnelli, E., Puoti, M., Bruno, R., Gaeta, G., et al. (2014). Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease. NEW MICROBIOLOGICA, 37(4), 423-438. Dettagli
  162. Armenia, D., Soulie, C., Di Carlo, D., Fabeni, L., Gori, C., Forbici, F., et al. (2014). A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. PLOS ONE, 9(8) [10.1371/journal.pone.0105853]. Dettagli
  163. Mennini, F.S., Marcellusi, A., Andreoni, M., Gasbarrini, A., Salomone, S., & Craxì, A. (2014). Health policy model: Long-term Predictive results associated with the management of hepatitis C virus-induced diseases in Italy. CLINICOECONOMICS AND OUTCOMES RESEARCH, 6(1), 303-310 [10.2147/CEOR.S62092]. Dettagli
  164. Marcotullio, S., Ammassari, A., Andreoni, M., Antinori, A., Bonora, S., d'Arminio Monforte, A., et al. (2014). Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology. NEW MICROBIOLOGICA, 37(2), 163-175. Dettagli
  165. Santoro, M., Fabeni, L., Armenia, D., Alteri, C., Di Pinto, D., Forbici, F., et al. (2014). Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels. CLINICAL INFECTIOUS DISEASES, 58(8), 1156-1164 [10.1093/cid/ciu020]. Dettagli
  166. Meini, G., Rossetti, B., Bianco, C., Ceccherini-Silberstein, F., Di Giambenedetto, S., Sighinolfi, L., et al. (2014). Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 69(3), 735-741 [10.1093/jac/dkt426]. Dettagli
  167. Svicher, V., Alteri, C., Montano, M., Nori, A., D'Arrigo, R., Andreoni, M., et al. (2014). Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. INFECTION, 42(1), 61-71 [10.1007/s15010-013-0510-3]. Dettagli
  168. Cudillo, L., Ceresoli, E., Sarmati, L., Mariotti, B., Viscione, M., De Majo, A., et al. (2014). Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. BONE MARROW TRANSPLANTATION, 49(4), 595-596. Dettagli
  169. d'Arminio Monforte, A., Gianotti, N., Cozzi-Lepri, A., Pinnetti, C., Andreoni, M., di Perri, G., et al. (2014). Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting. ANTIVIRAL THERAPY, 19(3), 319-324. Dettagli
  170. Surdo, M., Balestra, E., Saccomandi, P., Di Santo, F., Montano, M., Di Carlo, D., et al. (2013). Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. PLOS ONE, 8(7), e68076-e68076 [10.1371/journal.pone.0068076]. Dettagli
  171. Parisi, S.G., Andreis, S., Mengoli, C., Scaggiante, R., Cruciani, M., Ferretto, R., et al. (2013). A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. BMC INFECTIOUS DISEASES [10.1186/1471-2334-13-314]. Dettagli
  172. Cento, V., Van Hemert, F., Neumann Fraune, M., Mirabelli, C., Di Maio, V., Salpini, R., et al. (2013). Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen. JOURNAL OF INFECTION, 67(4), 303-312 [10.1016/j.jinf.2013.05.008]. Dettagli
  173. Salpini, R., Alteri, C., Cento, V., Pollicita, M., Micheli, V., Gubertini, G., et al. (2013). Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. JOURNAL OF MEDICAL VIROLOGY, 85(6), 996-1004 [10.1002/jmv.23567]. Dettagli
  174. Santoro, M., Armenia, D., Alteri, C., Flandre, P., Calcagno, A., Santoro, M., et al. (2013). Impact of pre-therapy viral load on virological response to modern first-line HAART. ANTIVIRAL THERAPY, 18(7), 867-876 [10.3851/IMP2531]. Dettagli
  175. Mve Mvondo, C., D'Auria, F., Sordillo, P., Pellegrino, A., Andreoni, M., & Chiariello, L. (2013). Candida parapsilosis endocarditis on a prosthetic aortic valve with unclear echocardiographic features. CARDIOVASCULAR JOURNAL OF AFRICA, 23(24(3)), 7-8 [10.5830/CVJA-2013-006]. Dettagli
  176. Salpini, R., Alteri, C., Cento, V., Pollicita, M., Micheli, V., Gubertini, G., et al. (2013). Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. JOURNAL OF MEDICAL VIROLOGY, 85(6), 996-1004. Dettagli
  177. Scognamiglio, P., Chiaradia, G., De Carli, G., Giuliani, M., Mastroianni, C.M., Aviani Barbacci, S., et al. (2013). The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis. BMC INFECTIOUS DISEASES, 13(1), 473 [10.1186/1471-2334-13-473]. Dettagli
  178. Svicher, V., Cento, V., Rozera, G., Abbate, I., Santoro, M., Armenia, D., et al. (2013). The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing. PLOS ONE, 8(1) [10.1371/journal.pone.0053603]. Dettagli

    10.1371/journal.pone.0053603

    Citazione
    Svicher, V., Cento, V., Rozera, G., Abbate, I., Santoro, M., Armenia, D., et al. (2013). The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing. PLOS ONE, 8(1) [10.1371/journal.pone.0053603].
    Data
    2013
    id
    PUBBLICAZIONE_156780
    Tipologia
    Articolo su rivista
    SSD
    Settore MED/07 - Microbiologia e Microbiologia Clinica
    Tutti gli Autori
    The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing
    tipologia
    Svicher, V; Cento, V; Rozera, G; Abbate, I; Santoro, M; Armenia, D; Fabeni, L; Bruselles, A; Latini, A; Palamara, G; Micheli, V; Rizzardini, G; Gori, C; Forbici, F; Ippolito, G; Andreoni, M; Antinori, A; Ceccherini Silberstein, F; Capobianchi, M; Perno, CF
  179. Sarmati, L., Parisi, S.G., Montano, M., Andreis, S., Scaggiante, R., Galgani, A., et al. (2012). Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 67(12), 2932-2938. Dettagli
  180. Andreoni, M., Giacometti, A., Maida, I., Meraviglia, P., Ripamonti, D., & Sarmati, L. (2012). HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 16(11), 1473-1483. Dettagli
  181. Santoro, M., Armenia, D., Fabeni, L., Santoro, M., Gori, C., Forbici, F., et al. (2012). The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients. CLINICAL MICROBIOLOGY AND INFECTION, 18(8) [10.1111/j.1469-0691.2012.03905.x]. Dettagli
  182. Ceccarelli, L., Calisti, G., Delle Rose, D., Ricciardi, A., Maffongelli, G., Sordillo, P., et al. (2012). Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. INFECTION, 40(4), 459-462. Dettagli
  183. Marcotullio, S., Andreoni, M., Antinori, A., d'Arminio Monforte, A., Di Perri, G., Galli, M., et al. (2012). The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection. NEW MICROBIOLOGICA, 35(3), 259-277. Dettagli
  184. Greco, E., Quintiliani, G., Santucci, M.B., Serafino, A., Ciccaglione, A., Marcantonio, C., et al. (2012). Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(21), E1360-E1360-8 [10.1073/pnas.1200484109]. Dettagli
  185. Antinori, A., Marcotullio, S., Ammassari, A., Andreoni, M., Angarano, G., Armignacco, O., et al. (2012). Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. NEW MICROBIOLOGICA, 35(2), 113-159. Dettagli
  186. Parisi, S.G., Andreis, S., Mengoli, C., Scaggiante, R., Ferretto, R., Manfrin, V., et al. (2012). Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy. JOURNAL OF CLINICAL MICROBIOLOGY, 50(2), 258-263 [10.1128/JCM.06022-11]. Dettagli
  187. Andreoni, M., & Perno, C. (2012). Positioning of HIV-protease inhibitors in clinical practice. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 16(1), 10-18. Dettagli
  188. Svicher, V., Cento, V., Bernassola, M., Neumann-Fraune, M., Van Hemert, F., Chen, M., et al. (2012). Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. ANTIVIRAL RESEARCH, 93(1), 86-93 [10.1016/j.antiviral.2011.10.022]. Dettagli
  189. Andreoni, M., & Perno, C. (2012). Positioning of HIV-protease inhibitors in clinical practice. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 16(1), 10-18. Dettagli
  190. Ceccarelli, L., Salpini, R., Moudourou, S., Cento, V., Santoro, M., Fokam, J., et al. (2012). Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. JOURNAL OF MEDICAL VIROLOGY, 84(5), 721-727 [10.1002/jmv.23244]. Dettagli
  191. Cento, V., Mirabelli, C., Salpini, R., Dimonte, S., Artese, A., Costa, G., et al. (2012). HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors. PLOS ONE, 7(7), e39652-e39652 [10.1371/journal.pone.0039652]. Dettagli
  192. Cento, V., Van Hemert, F., Di Maio, V., Salpini, R., Mirabelli, C., Bertoli, A., et al. (2012). Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen. In JOURNAL OF HEPATOLOGY (pp.S198-S199). Dettagli
  193. Nicastri, E., Dori, L., Buonomini, A.R., Tommasi, C., De Nardo, P., Bellagamba, R., et al. (2012). HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. AIDS, 26(11), 1451-1452 [10.1097/QAD.0b013e3283550b47]. Dettagli
  194. Salpini, R., Ceccarelli, L., Fokam, J., Nanfack, A., Torimiro, J., Sarmati, L., et al. (2012). HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON. In JOURNAL OF HEPATOLOGY (pp.S66-S66). Dettagli
  195. Svicher, V., Alteri, C., Montano, M., D'Arrigo, R., Andreoni, M., Angarano, G., et al. (2012). Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group. NEW MICROBIOLOGICA, 35(1), 17-25. Dettagli
  196. Svicher, V., Mirabelli, C., Cento, V., Salpini, R., Di Maio, V., Bertoli, A., et al. (2012). Key patterns of HBX and pre-S1/S2 mutations are involved in mechanisms underlying HBV-induced hepatocellular carcinoma in vivo. Paper presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, SPAIN [10.1016/S0168-8278(12)60500-5]. Dettagli
  197. Ceccarelli, L., Salpini, R., Sarmati, L., Svicher, V., Bertoli, A., Sordillo, P., et al. (2011). Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy. JOURNAL OF INFECTION, 65(2) [10.1016/j.jinf.2011.11.021]. Dettagli
  198. Svicher, V., Cento, V., Bernassola, M., Neumann-Fraune, M., Hemert, F., Chen, M., et al. (2011). Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. ANTIVIRAL RESEARCH, 93(1), 86-93 [10.1016/j.antiviral.2011.10.022]. Dettagli
  199. Sarrecchia, C., Svicher, V., Volpi, A., Salpini, R., Ceccarelli, L., Sordillo, P., et al. (2011). Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. INFECTION [10.1007/s15010-011-0127-3]. Dettagli
  200. Antinori, A., Marcotullio, S., Ammassari, A., Andreoni, M., Angarano, G., Carosi, G., et al. (2011). Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons. NEW MICROBIOLOGICA, 34, 109-146. Dettagli
  201. Antinori, A., Marcotullio, S., Ammassari, A., Andreoni, M., Angarano, G., Carosi, G., et al. (2011). Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-clinical Management of HIV-1 Infected Persons. NEW MICROBIOLOGICA, 34, 109-146. Dettagli
  202. Parisi, S.G., Andreoni, C., Sarmati, L., Boldrin, C., Buonomini, A.R., Andreis, S., et al. (2011). HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. JOURNAL OF CLINICAL MICROBIOLOGY, 49(4), 1441-1445 [10.1128/JCM.02564-10]. Dettagli
  203. Svicher, V., Balestra, E., Cento, V., Sarmati, L., Dori, L., Vandenbroucke, I., et al. (2011). HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. ANTIVIRAL RESEARCH, 90(1), 42-53 [10.1016/j.antiviral.2011.02.005]. Dettagli
  204. Maserati, R., Brandolini, M., Cattelan, A., Orani, A., Sighinolfi, L., Andreoni, M., et al. (2011). Once-a-day (QD) vs. Twice-daily (BID) Nevirapine as Simplification in PI-Treated Patients after 2 mos. of BID Induction. CURRENT HIV RESEARCH. Dettagli
  205. Parisi, S.G., Boldrin, C., Andreis, S., Ferretto, R., Fuser, R., Malena, M., et al. (2011). KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection. JOURNAL OF MEDICAL VIROLOGY, 83(3), 384-390 [10.1002/jmv.21987]. Dettagli
  206. D'Ettorre, G., Forcina, G., Ceccarelli, G., Andreotti, M., Andreoni, C., Rizza, C., et al. (2011). Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy. JOURNAL OF CHEMOTHERAPY, 23(1), 24-27. Dettagli
  207. Cento, V., Svicher, V., Rozera, G., Abbate, I., Santoro, M., Armenia, D., et al. (2011). The Genotypic False Positive Rate Determined by Population V3-Sequencing can Predict the Burden of X4 Quasispecies Detected by Pyrosequencing. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia. Dettagli
  208. Santoro, M., Armenia, D., Fabeni, L., Santoro, M., Gori, C., Forbici, F., et al. (2011). The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia. Dettagli
  209. Sarrecchia, C., Svicher, V., Volpi, A., Salpini, R., Ceccarelli, L., Sordillo, P., et al. (2011). Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. INFECTION [10.1007/s15010-011-0127-3.]. Dettagli
  210. Surdo, M., Balestra, E., Saccomandi, P., Di Santo, F., Svicher, V., Alteri, C., et al. (2011). Dual mixed (but not X4) tropic-HIV-1 isolates can replicate in human primary macrophages and are inhibited by CCR5- inhibitors. Paper presented at 3th ICAR – Italian Conference on AIDS and Retroviruses, Firenze, Italia. Dettagli
  211. Svicher, V., Alteri, C., Artese, A., Zhang, J., Costa, G., Mercurio, F., et al. (2011). Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage. ANTIVIRAL THERAPY, 16(7), 1035-1045. Dettagli
  212. Svicher, V., Cento, V., Bernassola, M., Neumann Fraune, M., Salpini, R., Longo, R., et al. (2011). Specific HBSAG Genetic- Determinants are associated with occult HBV-infection in vivo and HBSAG detection. Paper presented at 46th Annual meeting of the European Association for the study of the liver, Berlin, Germany. Dettagli
  213. Svicher, V., Cento, V., Bernassola, M., Neumann-Fraune, M., Chen, M., Salpini, R., et al. (2011). Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection. Paper presented at International Workshop on HIV & Hepatitis virus Drug Resistance and curative strategies, Los Cabos (Mexico). Dettagli
  214. Friis-Møller, N., Thiébaut, R., Reiss, P., Weber, R., Monforte, A.D., De Wit, S., et al. (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 17(5), 491-501 [10.1097/HJR.0b013e328336a150]. Dettagli
  215. Turriziani, O., Andreoni, M., & Antonelli, G. (2010). Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection. CLINICAL MICROBIOLOGY AND INFECTION, 16(10), 1518-1524. Dettagli
  216. Ceccherini-Silberstein, F., Van Baelen, K., Armenia, D., Trignetti, M., Rondelez, E., Fabeni, L., et al. (2010). Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 54(9), 3938-3948 [10.1128/AAC.01720-09]. Dettagli
  217. Sarmati, L., Parisi, S.G., Andreoni, C., Nicastri, E., Buonomini, A.R., Boldrin, C., et al. (2010). Switching of inferred tropism caused by HIV during interruption of antiretroviral therapy. JOURNAL OF CLINICAL MICROBIOLOGY, 48(7), 2586-2588. Dettagli
  218. Svicher, V., D'Arrigo, R., Alteri, C., Andreoni, M., Angarano, G., Antinori, A., et al. (2010). Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. NEW MICROBIOLOGICA, 33(3), 195-206. Dettagli
  219. Baroncelli, S., Villani, P., Weimer, L., Ladisa, N., Francisci, D., Tommasi, C., et al. (2010). Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration. THE ANNALS OF PHARMACOTHERAPY, 44(5), 838-843 [10.1345/aph.1M688]. Dettagli
  220. Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383 [10.1002/ajh.21685]. Dettagli
  221. Sarmati, L., Beltrame, A., Dori, L., Maffongelli, G., Cudillo, L., De Angelis, G., et al. (2010). Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. AMERICAN JOURNAL OF HEMATOLOGY, 85(5), 380-383 [10.1002/ajh.21685]. Dettagli
  222. Battagin, G., Sarmati, L., Sordillo, P., Picchi, G., Calisti, G., Ceccarelli, L., et al. (2010). Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. CASES JOURNAL, 3(3), 37. Dettagli
  223. Dori, L., Buonomini, A.R., Viscione, M., Sarmati, L., & Andreoni, M. (2010). A case of rhabdomiolysis associated with raltegravir use. AIDS, 24(3), 473-475 [10.1097/QAD.0b013e328334cc4a]. Dettagli
  224. Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), 488-492 [10.1016/j.ijid.2009.01.020]. Dettagli
  225. Beltrame, A., Sarmati, L., Cudillo, L., Cerretti, R., Picardi, A., Anemona, L., et al. (2009). A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13(6), e488-e492 [10.1016/j.ijid.2009.01.020]. Dettagli
  226. Antinori, A., Ammassari, A., Torti, C., Marconi, P., Andreoni, M., Angarano, G., et al. (2009). Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy. INFECTION, 37(3), 270-282 [10.1007/s15010-008-8134-8]. Dettagli
  227. Bonora, S., Nicastri, E., Calcagno, A., Gonzalez De Requena, D., D'Ettorre, G., Sarmati, L., et al. (2009). Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation. JOURNAL OF MEDICAL VIROLOGY, 81(3), 400-405 [10.1002/jmv.21405]. Dettagli
  228. Bonora S., N.E. (2009). Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation. JOURNAL OF MEDICAL VIROLOGY, 81(3), 400-405 [10.1002/jmv.21405]. Dettagli
  229. Monini, P., Sgadari, C., Grosso, M.g., Bellino, S., Di Biagio, A., Toschi, E., et al. (2009). Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir. AIDS, 23(4), 534-538 [10.1097/QAD.0b013e3283262a8d]. Dettagli
  230. Sarmati L., A.C. (2009). Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment. JOURNAL OF MEDICAL VIROLOGY, 81(3), 481-487 [10.1002/jmv.21424]. Dettagli
  231. Sarrecchia, C., Volpi, A., Sordillo, P., & Andreoni, M. (2009). Multidrug resistance after lamivudine therapy for chronic hepatitis B. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 13, 133-134 [10.1016/j.ijid.2008.08.005]. Dettagli
  232. Nicastri E., P.L. (2008). HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens. CURRENT HIV RESEARCH, 6(3), 261-266 [10.2174/157016208784325010]. Dettagli
  233. Tommasi, C., Nicastri, E., Corpolongo, A., Ivanovic, J., Notari, S., Ascenzi, P., et al. (2008). Stopping antiretroviral therapy: Role for therapeutic drug monitoring [1]. AIDS, 22(2), 315-316. Dettagli
  234. Antinori, A., Trotta, M., Lorenzini, P., Torti, C., Gianotti, N., Maggiolo, F., et al. (2007). Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation. ANTIVIRAL THERAPY, 12(8), 1175-1183. Dettagli
  235. Nicastri E., L.S. (2007). Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60(4), 724-732 [10.1093/jac/dkm302]. Dettagli
  236. Sarmati L., B.S. (2007). Human herpesvirus 8 and human herpesvirus 2 infections in prison population. JOURNAL OF MEDICAL VIROLOGY, 79(2), 167-173 [10.1002/jmv.20774]. Dettagli
  237. Sarmati, L., Parisi, S.G., Nicastri, E., D'Ettorre, G., Andreoni, C., Dori, L., et al. (2007). Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens. JOURNAL OF MEDICAL VIROLOGY, 79(7), 880-886 [10.1002/jmv.20914]. Dettagli
  238. Carosi, G., Torti, C., Andreoni, M., Angarano, G., Antinori, A., Bonora, S., et al. (2006). Key questions in antiretroviral therapy: Italian Consensus Workshop (2005). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 57(6), 1055-1064 [10.1093/jac/dkl113]. Dettagli
  239. Antinori, A., Trotta, M., Nasta, P., Bini, T., Bonora, S., Castagna, A., et al. (2006). Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients. ANTIVIRAL THERAPY, 11(2), 233-243. Dettagli
  240. Babudieri S., L.B. (2005). Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy. JOURNAL OF MEDICAL VIROLOGY, 76(3), 311-317 [10.1002/jmv.20375]. Dettagli
  241. Nicastri E., C.A. (2005). Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART. JOURNAL OF MEDICAL VIROLOGY, 76(2), 153-160 [10.1002/jmv.20352]. Dettagli
  242. Nicastri, E., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., Geraci, A., et al. (2005). Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS, 19(6), 577-583 [10.1097/01.aids.0000163934.22273.06]. Dettagli
  243. Sarmati, L., Parisi, S.G., Nicastri, E., D'Ettorre, G., Palmisano, L., Andreotti, M., et al. (2005). Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy. JOURNAL OF CLINICAL MICROBIOLOGY, 43(12), 6183-6185 [10.1128/JCM.43.12.6183-6185.2005]. Dettagli
  244. Suligoi B., D.R. (2005). Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 72(1), 33-36. Dettagli
  245. Volpi, A., Sarmati, L., Suligoi, B., Montano, M., Rezza, G., & Andreoni, M. (2004). Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. JOURNAL OF MEDICAL VIROLOGY, 74(3), 467-472. Dettagli
  246. D'Ettorre, G., Forcina, G., Andreotti, M., Sarmati, L., Palmisano, L., Andreoni, M., et al. (2004). Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 135(2), 280-285 [10.1111/j.1365-2249.2004.02373.x]. Dettagli
  247. Nicastri E., S.L. (2004). Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 20(8), 816-818 [10.1089/0889222041725271]. Dettagli
  248. Nicastri, E., Sarmati, L., Dori, L., Montano, M., D'Ettorre, G., Buonomini, A.R., et al. (2004). Viral growth assay to evaluate the replicative capacity of HIV-1 isolates. JOURNAL OF VIROLOGICAL METHODS, 115(2), 199-205 [10.1016/j.jviromet.2003.09.032]. Dettagli
  249. Sarmati L., M.M. (2004). Discordant response to HAART: Reduction of viremia and replicative capacity of HIV strains in patients after genotype guided change of therapy. NEW MICROBIOLOGICA, 27(2 SUPPL. 1), 95-98. Dettagli
  250. Sarmati, L., Nicastri, E., Montano, M., Dori, L., Buonomini, A.R., D'Ettorre, G., et al. (2004). Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy. JOURNAL OF MEDICAL VIROLOGY, 72(4), 511-516 [10.1002/jmv.20030]. Dettagli
  251. Sarmati, L., Ticconi, C., Santangelo, R., Montano, M., Pietropolli, A., Rezza, G., et al. (2004). Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission. JOURNAL OF MEDICAL VIROLOGY, 72(3), 462-466 [10.1002/jmv.20012]. Dettagli
  252. Schinaia, N., Kodra, Y., Sarmati, L., Andreoni, M., Bino, S., Qyra, S., et al. (2004). Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 19(5), 467-469 [10.1023/B:EJEP.0000027358.38997.66]. Dettagli
  253. Nicastri, E., Sarmati, L., Andreoni, M., & Parisi, S.G. (2003). Human immunodeficiency virus polymorphisms and zidovudine resistance. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47(8), 2714-2715. Dettagli
  254. Nicastri E., S.L. (2003). Human immunodeficiency virus polymorphisms and zidovudine resistance [3] (multiple letters). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47(8), 2714-2715 [10.1128/AAC.47.8.2714-2715.2003]. Dettagli
  255. Nicastri E., S.L. (2003). Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. JOURNAL OF MEDICAL VIROLOGY, 69(1), 1-6 [10.1002/jmv.10269]. Dettagli
  256. Nicastri, E., Sarmati, L., & Andreoni, M. (2003). Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2]. AIDS, 17(3), 447-448 [10.1097/00002030-200302140-00022]. Dettagli
  257. Nicastri, E., Sarmati, L., Andreoni, M., Joly, V., Descamps, D., Flandre, P., et al. (2003). Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 47(3), 1176 [10.1128/AAC.47.3.1176.2003]. Dettagli
  258. Nicastri, E., Sarmati, L., D'Ettorre, G., Parisi, S., Palmisano, L., Galluzzo, C., et al. (2003). High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis. JOURNAL OF CLINICAL MICROBIOLOGY, 41(7), 3007-3012 [10.1128/JCM.41.7.3007-3012.2003]. Dettagli
  259. Sarmati L., A.M. (2003). Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 68(4), 501-502. Dettagli
  260. Sarmati L., N.E. (2003). Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. JOURNAL OF CLINICAL MICROBIOLOGY, 41(4), 1760-1762 [10.1128/JCM.41.4.1760-1762.2003]. Dettagli
  261. Sarmati, L., Andreoni, M., Suligoi, B., Bugarini, R., Uccella, I., Pozio, E., et al. (2003). Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 68(4), 501-502. Dettagli
  262. Sarmati, L., Ticconi, C., Santangelo, R., Montano, M., Rezza, G., Andreoni, M., et al. (2003). Does the risk of abortion increase in women with high human herpesvirus-8 antibody titers? [1] (multiple letters). THE JOURNAL OF INFECTIOUS DISEASES, 188(1), 173-175 [10.1086/375830]. Dettagli
  263. Serraino D., C.R. (2003). Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria. INFECTION, 31(1), 47-50 [10.1007/s15010-002-3107-9]. Dettagli
  264. Parisi, S.G., Mazzi, R., Sarmati, L., Carolo, G., Uccella, I., Rianda, A., et al. (2002). Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. AIDS, 16(7), 1089-1091. Dettagli
  265. Andreoni, M., Sarmati, L., Nicastri, E., El Sawaf, G., El Zalabani, M., Uccella, I., et al. (2002). Primary human herpesvirus 8 infection in immunocompetent children. JAMA, 287(10), 1295-1300. Dettagli
  266. Broccolo, F., Locatelli, G., Sarmati, L., Piergiovanni, S., Veglia, F., Andreoni, M., et al. (2002). Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids. JOURNAL OF CLINICAL MICROBIOLOGY, 40(12), 4652-4658 [10.1128/JCM.40.12.4652-4658.2002]. Dettagli
  267. D'Ettorre, G., Forcina, G., Andreotti, M., Sarmati, L., Palmisano, L., Galluzzo, C.M., et al. (2002). Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production. AIDS, 16(14), 1877-1885 [10.1097/00002030-200209270-00004]. Dettagli
  268. Fernandez, L., Serraino, D., Rezza, G., Lence, J., Ortiz, R., Cruz, T., et al. (2002). Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba. BRITISH JOURNAL OF CANCER, 87(11), 1253-1256 [10.1038/sj.bjc.6600613]. Dettagli
  269. Malnati, M., Broccolo, F., Nozza, S., Sarmati, L., Ghezzi, S., Locatelli, G., et al. (2002). Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. BLOOD, 100(5), 1575-1578. Dettagli
  270. Parisi, S.G., Sarmati, L., Pappagallo, M., Mazzi, R., Carolo, G., Farchi, F., et al. (2002). Prevalence trend and correlates of HHV-8 infection in HIV-infected patients. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 29(3), 295-299. Dettagli
  271. Sarmati, L., Nicastri, E., Parisi, S.g., D'Ettorre, G., Mancino, G., Narciso, P., et al. (2002). Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells. JOURNAL OF CLINICAL MICROBIOLOGY, 40(2), 335-340 [10.1128/JCM.40.2.335-340.2002]. Dettagli
  272. Andreoni, M., Goletti, D., Pezzotti, P., Pozzetto, A., Monini, P., Sarmati, L., et al. (2001). Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. JOURNAL OF INFECTION, 43(3), 195-199. Dettagli
  273. Schatz, O., Monini, P., Neipel, F., Schulz, T.F., Andreoni, M., Erb, P., et al. (2001). Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. JOURNAL OF MEDICAL VIROLOGY, 65(1), 123-132. Dettagli
  274. Nicastri, E., Ercoli, L., Sarmati, L., d'Ettorre, G., Iudicone, P., Massetti, P., et al. (2001). Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus. JOURNAL OF MEDICAL VIROLOGY, 64(3), 232-237. Dettagli
  275. Andreoni, M., Goletti, D., Pezzotti, P., Pozzetto, A., Monini, P., Sarmati, L., et al. (2001). Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. JOURNAL OF INFECTION, 195-199. Dettagli
  276. Mazzi, R., Parisi, S.G., Sarmati, L., Uccella, I., Nicastri, E., Carolo, G., et al. (2001). Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1]. AIDS, 15(15), 2061-2062 [10.1097/00002030-200110190-00026]. Dettagli
  277. Rezza, G., Danaya, R., Wagner, T., Sarmati, L., Owen, I., Monini, P., et al. (2001). Human herpesvirus-8 and other viral infections, Papua New Guinea. EMERGING INFECTIOUS DISEASES, 7(5), 893-895. Dettagli
  278. Sarmati, L., D'Ettorre, G., Nicastri, E., Ercoli, L., Uccella, I., Massetti, P., et al. (2001). Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 8(4), 822-824 [10.1128/CDLI.8.4.822-824.2001]. Dettagli
  279. Sarmati, L., Parisi, S.g., Nicastri, E., D'Ettorre, G., Andreoni, C., Dori, L., et al. (2001). Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations. JOURNAL OF MEDICAL VIROLOGY, 65(4), 631-636 [10.1002/jmv.2083]. Dettagli
  280. Sarrecchia, C., Niutta, P., Testore, G.P., Sordillo, P., Proietti, F., & Andreoni, M. (2001). Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon. RECENTI PROGRESSI IN MEDICINA, 92(5), 336-339. Dettagli
  281. Serraino, D., Toma, L., Andreoni, M., Buttò, S., Tchangmena, O., Sarmati, L., et al. (2001). A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 17(9), 871-876. Dettagli
  282. Testore, G.P., Falco, F., Sarrecchia, C., Sordillo, P., Bontempo, G., & Andreoni, M. (2001). Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 41(1-2), 23-27. Dettagli
  283. Rezza, G., Dorrucci, M., Serraino, D., Andreoni, M., Giuliani, M., Zerboni, R., et al. (2000). Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. AIDS, 14(11), 1647-1653. Dettagli
  284. Rezza, G., Tchangmena, O.B., Andreoni, M., Bugarini, R., Toma, L., Bakary, D.K., et al. (2000). Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. SEXUALLY TRANSMITTED DISEASES, 27(3), 159-164. Dettagli
  285. Andreoni, M., Parisi, S.G., Sarmati, L., Nicastri, E., Ercoli, L., Mancino, G., et al. (2000). ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. AIDS, 14(1), 23-29. Dettagli
  286. Nicastri, E., Sarmati, L., Andreoni, M., Biggar, R.J., Black, F., & Whitby, D. (2000). Human herpesvirus 8 in Brazilian Amerindians: Does vertical transmission play a role? [1] (multiple letters). THE JOURNAL OF INFECTIOUS DISEASES, 182(5), 1574-1575. Dettagli
  287. Testore, G.P., Uccella, I., Sarrecchia, C., Mattei, A., Impagliazzo, A., & Andreoni, M. (2000). Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients. JOURNAL OF CHEMOTHERAPY, 12(5), 412-415. Dettagli
  288. Ascoli, V., Sirianni, M.c., Mezzaroma, I., Mastroianni, C.m., Vullo, V., Andreoni, M., et al. (1999). Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease. ANNALS OF DIAGNOSTIC PATHOLOGY, 3(6), 357-363 [10.1053/ADPA00300357]. Dettagli
  289. Rezza, G., Andreoni, M., Dorrucci, M., Pezzotti, P., Monini, P., Zerboni, R., et al. (1999). Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 91(17), 1468-1474. Dettagli
  290. Andreoni, M., El-Sawaf, G., Rezza, G., Ensoli, B., Nicastri, E., Ventura, L., et al. (1999). High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 91(5), 465-469. Dettagli
  291. Nicastri E., S.L. (1999). Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects. AIDS, 13(11), 1333-1336 [10.1097/00002030-199907300-00009]. Dettagli
  292. Andreoni, M., Sarmati, L., Nicastri, E., Ventura, L., Ercoli, L., Parisi, S.G., et al. (1998). Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy. JOURNAL OF MEDICAL VIROLOGY, 56(4), 332-336. Dettagli
  293. Nicastri, E., Ercoli, L., Sarmati, L., Ventura, L., Parisi, S.G., Ciapetti, C., et al. (1998). Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease. JOURNAL OF HUMAN VIROLOGY. Dettagli
  294. Ercoli, L., Sarmati, L., Nicastri, E., Giannini, G., Galluzzo, C., Vella, S., et al. (1997). HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity. AIDS, 11(10), 1211-1217. Dettagli
  295. Andreoni, M., Sarmati, L., Ercoli, L., Nicastri, E., Giannini, G., Galluzzo, C., et al. (1997). Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. AIDS RESEARCH AND HUMAN RETROVIRUSES, 13(7), 555-561. Dettagli
  296. Sarmati L., N.E. (1997). Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment. JOURNAL OF MEDICAL VIROLOGY, 53(4), 313-318 [10.1002/(SICI)1096-9071(199712)53:4<313::AID-JMV1>3.0.CO;2-A]. Dettagli
  297. Vella, S., Galluzzo, C., Giannini, G., Pirillo, M.F., Duncan, I., Jacobsen, H., et al. (1996). Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. ANTIVIRAL RESEARCH, 29(1), 91-93. Dettagli
  298. Ercoli, L., Sarmati, L., Parisi, S., Mancino, G., DE SANTIS, G., Bonanno, E., et al. (1996). Human immunodeficiency virus infection of human bone marrow stromal myoid cells. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 28(4), 335-340 [10.3109/00365549609037915]. Dettagli
  299. Ercoli, L., Sarmati, L., Parisi, S., Mancino, G., De Santis, G., Bonanno, E., et al. (1996). Human immunodeficiency virus infection of human bone marrow stromal myoid cells. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 28(4), 335-340. Dettagli
  300. Ercoli, L., Sarmati, L., El Sawaf, G., Cochi, S., Lanti, T., Iudicone, P., et al. (1995). Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients. AIDS RESEARCH AND HUMAN RETROVIRUSES, 11(10), 1203-1207. Dettagli
  301. Sarmati, L., Ercoli, L., Parisi, S.g., Rocchi, G., Giannini, G., Galluzzo, C., et al. (1994). High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 7(1), 10-14. Dettagli
  302. Andreoni, M., Sarmati, L., Parisi, S.G., Ercoli, L., & Rocchi, G. (1992). Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma. JOURNAL OF MEDICAL VIROLOGY, 38(3), 207-213. Dettagli
  303. Sarmati, L., Parisi, S.G., Armignacco, O., Sarrecchia, C., Antonucci, G., Ercoli, L., et al. (1992). HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI]. Paper presented at International Conference on AIDS, Amsterdam. Dettagli
  304. Andreoni, M., El-Bassiouni, E.A., Giannini, F., Rocchi, G., & Vatalaro, F. (1989). Definition and design of an integrated satellite system for telemedicine and distance learning. Paper presented at 37° convegno int. delle comunicazioni, Genova - Italia. Dettagli
  305. Sarmati, L., Andreoni, M., Arcese, W., Pica, F., Bianchi, A., Mauro, F., et al. (1987). L'infezione da Citomegalovirus in 16 pazienti sottoposti a trapianto di midollo. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE, 39, 935-936. Dettagli
  306. Andreoni M, R.L. (1985). Indagini sull'infezione da virus Herpes simplex in casi di vaginite aspecifica in gravidanza. vol. 37, p. 1009-1010. GIORNALE DI MALATTIE INFETTIVE E PARASSITARIE. Dettagli